3,922,877
Participants
Start Date
December 1, 2018
Primary Completion Date
April 30, 2021
Study Completion Date
April 30, 2021
No intervention
No intervention, epidemiological investigation
Kaiser Permanente, San Francisco
Lead Sponsor
Bayer
INDUSTRY